LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Taxol | 0.031623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | E04 |
| MCF 10A-H2B-mCherry | Etoposide | 0.56234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L03 |
| MCF 10A-H2B-mCherry | Taxol | 0.0056234 | 4.36 | 84.90 | 597 | 322 | 1.8508 | 1.7533 | MN20160318_Q02 | H06 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 4.36 | 84.90 | 639 | 322 | 1.9810 | 1.8522 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Taxol | 0.01 | 4.36 | 84.90 | 545 | 322 | 1.6895 | 1.6260 | MN20160318_Q02 | G22 |
| MCF 10A-H2B-mCherry | Etoposide | 0.56234 | 4.36 | 84.90 | 697 | 322 | 2.1608 | 1.9838 | MN20160318_Q02 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.36 | 84.90 | 615 | 322 | 1.9066 | 1.7961 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 4.36 | 84.90 | 657 | 322 | 2.0368 | 1.8937 | MN20160318_Q02 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.36 | 84.90 | 528 | 322 | 1.6368 | 1.5832 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Taxol | 0.0056234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H06 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.36 | 84.90 | 652 | 322 | 2.0213 | 1.8822 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Etoposide | 1 | 4.36 | 84.90 | 571 | 322 | 1.7702 | 1.6904 | MN20160318_Q02 | E13 |
| MCF 10A-H2B-mCherry | Taxol | 0.0056234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J11 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 4.36 | 84.90 | 462 | 322 | 1.4322 | 1.4101 | MN20160318_Q02 | F18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 4.36 | 84.90 | 680 | 322 | 2.1081 | 1.9458 | MN20160318_Q02 | L13 |
| MCF 10A-H2B-mCherry | Taxol | 0.0031623 | 4.36 | 84.90 | 9 | 322 | 0.0279 | -0.6882 | MN20160318_Q02 | M13 |
| MCF 10A-H2B-mCherry | Etoposide | 10 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L13 |
| MCF 10A-H2B-mCherry | Taxol | 0.0031623 | 4.36 | 84.90 | 769 | 322 | 2.3840 | 2.1401 | MN20160318_Q02 | M13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.36 | 84.90 | 691 | 322 | 2.1422 | 1.9705 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Taxol | 0.017783 | 4.36 | 84.90 | 488 | 322 | 1.5128 | 1.4796 | MN20160318_Q02 | H21 |